[E-Daily Starin Choi Hee-jae Reporter] The live-action film “Moana,” based on Disney’s mega intellectual property (IP) “Moana,” continues its box office run, holding the top spot for the sixth consecutive day. Poster for the movie “Moana” (Photo courtesy of The Walt Disney Company Korea) According to the Korean Film Council’s integrated computer network on the 14th, “Moana” drew 29,084 viewers on the 13th, securing the No. 1 spot at the box office. Its cumulative audience count stands at 540,553. “Moana” has been riding a wave of popularity, holding the top spot for six consecutive days since its release on the 8th. The mystery thriller “The Eye,” starring Shin Min-a, is also maintaining its box office momentum. “The Eye” recorded 26,902 viewers, bringing its cumulative total to 1,304,161. Third place went to the Disney-Pixar animated film “Toy Story 5.” It drew 17,731 viewers, bringing its cumulative total to 2,598,048. “Gunchye” took fourth place (6,106 viewers), and “David” took fifth (5,314 viewers). “Hope,” set to open on the 15th, took the top spot in advance ticket sales. As of 8:15 a.m. on the 14th, “Hope” had recorded 467,734 advance ticket sales. Sony Pictures’ “Spider-Man: Brand New Day,” set to open on the 29th, is also generating buzz after surpassing 100,895 advance ticket sales. Director Christopher Nolan’s new film “The Odyssey,” set to open on the 5th of next month, has 40,202 advance ticket sales. With several highly anticipated global films set to hit theaters, all eyes are on whether “Moana” can maintain its box office momentum.
The way global private equity fund (PEF) managers invest in rental housing is evolving. Previously, most cases involved directly purchasing individual properties. However, transactions have recently e…
SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
Medy-Tox Inc.(086900)Medytox continued its revenue growth in the second quarter of this year, driven by expanded overseas sales of botulinum toxin and dermal fillers, as well as the successful market …